Arcellx, Inc.

ACLXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$22.3M

▼ 79.4% YoY

Net Income

-$228.9M

▼ 113.3% YoY

EPS

$-4.07

▼ 103.5% YoY

Cash

$80.3M

▼ 24.1% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.